Table 2 Clinical outcomes in eRA cohort after 24 weeks of treatment

CDAI Remission, n (%)

28 (40)

2 (16.7)

8 (36.4)

10 (59)

8 (42)

0.16^b

CDAI^a

3.8 (0.1–28.3)

5 (1.6–15.5)

4.2 (0.2–19.2)

2.3 (0.1–28.3)

3.3 (0.1–18.5)

0.26^c

TJC 28^a

0.5 (0–19)

1 (0–11)

0 (0–4)

0 (0–19)

1 (0–15)

0.26^c

SJC 28^a

0.0 (0–6)

0 (0–1)

0 (0–6)

0 (0–6)

0 (0–3)

0.61^c

PGA^a

14.5 (0–92)

19 (2–62)

14.5 (2–92)

9 (0–60)

10 (0–76)

0.099^c

EGA^a

6.5 (0–40)

11 (1–34)

7.5 (0–40)

5 (0–24)

4 (0–22)

0.33^c